Instructions for Cystone 100 pills
English product name
Cystone
Release form
Tablets
Description Cystone:
The tablets are light brown in colour with emits of lighter and darker colour, round and double-convex.
1 tab.
stem biploid flower extract 65 mg
extract from the stems of the lingua 49 mg
marena core stem extract 16 mg
rhizome extract 16 mg
flaxseed extract solomon 16 mg
extract from the aboveground part of the onosma pritsvetnoy 16 mg
extract from the whole plant vernonia ash 16 mg
powder mumie purified 13 mg
silica lime powder 16 mg,
vegetable raw material mixtures treated over steam: The above-ground part of the sweet-scented basil, the seeds of horse beans, the fruit of the fallow Hawkers, the seeds of the shameful mimosa, the whole plant of the fragrant Pavonia, the whole plant of the field's tail, the seeds of the teak tree.
Auxiliary substances:
magnesium stearate,
cellulose microcrystalline,
sodium carboxymethyl cellulose,
crospovidone,
silicon dioxide colloidal (aerosyl).
100 pcs - plastic bottles (1) - cardboard packs.
ATC codes
G04BX Other preparations for the treatment of urological diseases
Clinical-pharmacological groups / Group affiliation
Phytopreparation with diuretic, lytolitic and anti-inflammatory effects
Active substance Cystone
powder mumie purified
stem biploid flower extract
extract from the stems of the lingua
marena core stem extract
rhizome extract
flaxseed extract solomon
extract from the aboveground part of the onosma pritsvetnoy
extract from the whole plant vernonia ash
silica lime powder
Pharmacotherapy group Cystone:
Nephrolithiasis, a plant-based treatment
Storage Conditions
The drug should be stored in a dry, inaccessible place for children at a temperature of 10° to 30°C.
Best before date
The shelf life is three years.
Testimony Cystone:
As part of complex therapy:
urinary disease;
crystalluria;
urinary tract infections (cystitis, pyelonephritis);
gout.
Method of use, course and dosage:
In the complex therapy of urolithiasis, the drug is prescribed in two tablets. twice a day for four to six months or before the release of stones.
In the complex treatment of urinary tract infections, the drug is prescribed two tabs. twice a day until the elimination of the process.
To prevent recurrence after surgical removal or release of stones - two tab. twice a day for 1 month, then one tab. twice a day for four - five months.
Contraindications for use
increased sensitivity to drug components.
Special Instructions
It should be borne in mind that the action of the drug Cyston develops gradually.
It is not recommended to use the drug for acute pain in the urinary tract area.
If acute pain occurs during treatment, stop taking the drug.
Terms of Sale
The drug is allowed to be used as a non-prescription drug.
- Nosology Cystone (ICD codes)
- M10
- Podagra
- N10
- Acute tubuloinsterstitial nephritis (acute pielonephritis)
- N11
- Chronic tubulointerstitial nephritis (chronic pyelonephritis)
- N20
- Kidney and Ureter Stones
- N21
- Lower urinary tract stones
- N30
- Cystitis
Pharmacological effect Cystone:
A combined plant preparation. It has diuretic, spasmolytic, lytolytic, antimicrobial and anti-inflammatory effects.
The preparation regulates the crystallocolloid balance in the case of dysmetabolic nephropathy and reduces the concentration of elements in the urine that promote the formation of stones (oxalic acid, calcium, hydroxyproline). Increases the level of elements that inhibit the process of stone formation (sodium, magnesium, potassium). By acting on mucin, the drug promotes the disintegration of stones, leading to their demineralization.
Prevents the accumulation of particles around the core of the stone, which prevents its further growth.
By stimulating diuresis and relaxing the smooth muscles of the urinary tract, Cyston promotes the removal of oxalate and phosphate salts, uric acid and small stones from the urinary tract.
Cyston has a bacteriostatic and bactericidal effect, especially in relation to Klebsiella spp., Pseudomonas aeruginosa, Escherichia coli and other gram-negative bacteria.
The lipolytic effect of the drug does not depend on the pH of urine.